Research Article
Construction of a Prognostic Immune-Related LncRNA Risk Model for Gastric Cancer
Table 5
Comparation of the clinicopathological characteristics between low and high expression groups.
| Variables | RP11-617F23.1 | value | Low expression (n = 32) | High expression (n = 32) |
| Age, years | 65.94 ± 6.90 | 67.84 ± 8.49 | 0.329 | Sex, male | 17 (53.1%) | 22 (68.8%) | 0.200 | CEA, U/ml | 20.54 ± 72.16 | 7.31 ± 20.63 | 0.692 | NLR | 2.00 ± 0.76 | 3.81 ± 2.34 | <0.001 | Tumor differentiation, poor | 16 (50.0%) | 24 (75.0%) | 0.039 | T stage, III-IV | 15 (46.9%) | 26 (81.3%) | 0.004 | Lymphatic invasion, positive | 14 (43.8%) | 22 (68.8%) | 0.044 |
|
|
Note: mean ± standard deviation, number (percent); NLR: neutrophil lymphocyte ratio; Mann–Whitney test; statistically significant. |